JAN 06, 2021 6:00 AM PST

COVID Patients Can't Stop and Smell the Roses

WRITTEN BY: Tara Fernandez

A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their sense of smell. On average, this olfactory dysfunction lingered for around three weeks. In a quarter of patients, their sense of smell was impaired for over two months.

The study, published in the Journal of Internal Medicine, was conducted by Jerome R. Lechien from Paris Saclay University and aimed to investigate how a marked decrease in olfactory function related to the severity of COVID-19 symptoms. Interestingly, only around five percent of moderate COVID cases and seven percent of critical cases lost their sense of smell.

"Olfactory dysfunction is more prevalent in mild COVID-19 forms than in moderate-to-critical forms, and 95% of patients recover their sense of smell at 6-months post-infection," said Lechien.

The temporary loss of smell, also known as anosmia, has been touted by experts as a better diagnostic indicator of the onset of infection than other common symptoms such as fever and cough. 

 

 

But why does SARS-CoV-2 infection interrupt patients’ ability to smell? Scientists initially suspected that the virus might be impacting the olfactory sensory neurons that detect and relay chemical signals from the nose to the brain. Follow up studies proved this not to be the case, as these neurons do not express the ACE2 receptor protein, the gateway for the coronavirus to enter human cells. 

Instead, SARS-CoV-2 is likely affecting the olfactory neurons’ support network—stem cells and cells lining blood vessels in the nasal passage. 

“Our findings indicate that the novel coronavirus changes the sense of smell in patients not by directly infecting neurons but by affecting the function of supporting cells,” explained Harvard Medical School scientist Sandeep Robert Datta.

On a positive note, COVID-related anosmia is a temporary condition.

“I think it’s good news, because once the infection clears, olfactory neurons don’t appear to need to be replaced or rebuilt from scratch,” added Datta. “But we need more data and a better understanding of the underlying mechanisms to confirm this conclusion.”

Sources: Harvard Medical School, Journal of Internal Medicine, EurekAlert.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 18, 2020
Clinical & Molecular DX
Open Your Heart to the World's Smallest Diagnostic Probe
SEP 18, 2020
Open Your Heart to the World's Smallest Diagnostic Probe
Certain health conditions require doctors to be able to observe tissues and organs in order to tell what’s wrong. ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
DEC 01, 2020
Cardiology
The Benefits of Exercise on Adipokine Levels for Post-Menopausal Women
DEC 01, 2020
The Benefits of Exercise on Adipokine Levels for Post-Menopausal Women
The benefits of a healthy lifestyle don’t just stop when you get older. Being active has been shown to improve pos ...
DEC 19, 2020
Clinical & Molecular DX
Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat
DEC 19, 2020
Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat
Researchers have developed a chip-based test that can determine pregnancy outcomes after the signs of a possible miscarr ...
DEC 29, 2020
Clinical & Molecular DX
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
DEC 29, 2020
Injectable Heart Health Tracker Now Picks Up COVID Red Flags
The statistics are a real eye-opener: in the United States, one person dies every 36 seconds from cardiovascular disease ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
Loading Comments...